$BSTC News
Last published 5y ago
- 5y agoBSTCNew patent application published for: Treatment Method and Product for Uterine Fibroids Using Purified CollagenaseUS Patent Applications (USPTO)
- 5y agoBSTCENDPBioSpecifics Announces Completion of Acquisition by Endo PharmaceuticalsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 5y agoENDPBSTCEndo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender OfferPR NewswireEndo International plc (Nasdaq: ENDP) ("Endo") today announced the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust...
- 6y agoBSTCRigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. BuyoutGlobeNewswireWILMINGTON, Del., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating BioSpecifics Technologies Corp. (“BioSpecifics”) (NASDAQ GM: BSTC) regarding...
- 6y agoBSTCENDPBioSpecifics Reports Third Quarter 2020 Financial and Operating ResultsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC) ("BioSpecifics" or the "Company"), a biopharmaceutical company that originated and continues to...
- 6y agoBSTCTNAVPRCPALSKMoore Kuehn Encourages TNAV, PRCP, ALSK, and BSTC Investors to Contact Law FirmGlobeNewswireNEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
- 6y agoBSTCDNKNEIGIPRCPMoore Kuehn Encourages BSTC, DNKN, EIGI, and PRCP Investors to Contact Law FirmPR NewswireMoore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
- 6y agoBSTCCITMYOKPEMoore Kuehn Encourages MYOK, BSTC, CIT, and PE and Investors to Contact Law FirmGlobeNewswireNEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
- 6y agoBSTCBioSpecifics to be Acquired by Endo PharmaceuticalsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC) announced today that it has entered into a definitive merger agreement under which Endo International...
- 6y agoENDPBSTCEndo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™PR NewswireEndo International plc (NASDAQ: ENDP) today announced it has agreed to acquire all of the outstanding shares of BioSpecifics Technologies Corp....
- 6y agoBSTCBioSpecifics to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech SummitPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics to Present at the H.C. Wainwright Virtual Healthcare ConferencePR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Reports Second Quarter 2020 Financial and Operating ResultsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Appoints Alex Monteith as Chief Business OfficerPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC) (the "Company"), a biopharmaceutical company that originated and continues to develop...
- 6y agoBSTCBioSpecifics Reports First Quarter 2020 Financial and Operating ResultsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Names Joseph Truitt as Permanent Chief Executive OfficerPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Adopts Replacement Stockholder Rights PlanPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Appoints Mike Sherman and Corey Fishman to Board of DirectorsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Appoints Joseph Truitt as Interim Chief Executive OfficerPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 6y agoBSTCBioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating ResultsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 7y agoBSTCBioSpecifics Reports Third Quarter 2019 Financial and Operating ResultsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 7y agoBSTCJennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of DirectorsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 7y agoBSTCBioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive OfficerPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 7y agoBSTCBioSpecifics Technologies Corp. Reports Second Quarter 2019 Financial and Operating ResultsPR NewswireBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...
- 10y agoBSTCBioSpecifics Technologies' (BSTC) Management on Q3 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoBSTCBioSpecifics Technologies' (BSTC) Q3 2015 Results - Earnings Call TranscriptEarnings Call Transcripts